Clinical Drug Trials

“Early pre-licensure studies on mefloquine were conducted predominantly among male prisoners, military personnel, and subjects in third-world countries. … The purported safety of mefloquine was so well established that when reports of severe psychiatric side effects, including amnesia, confusion and psychosis, first emerged in the literature following the drug’s early European licensure, these symptoms were frequently dismissed as coincidental or were later attributed by influential authors to the stresses of overseas travel, recreational drug use, or pre-existing or latent mental illness. Despite continued reports in the literature of severe psychiatric side effects following the drug’s U.S. licensure, it was only in 2001, after the drug had been in widespread use for over 15 years and the first formal blinded and controlled prospective studies were conducted in a representative civilian population, that mefloquine’s potent psychotropic capability became more widely appreciated.”

E. C. Ritchie, J. Block and R. L. Nevin, Psychiatric Side Effects of Mefloquine: Applications to Forensic Psychiatry, 2013.

Dr Remington Nevin

 American Flag Hawaii 1991

Under construction.

Canadian Flag Somalia 1992-1993

Under construction.

Australian Flag Somalia 1992-1993

Under construction.

Australian Flag Bougainville 1998-1999

Under construction.

Australian Flag Timor Leste 2000-2002

Under construction.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s